Characterization of prednisolone in controlled porosity osmotic pump pellets using solid-state NMR spectroscopy

被引:10
作者
Sotthivirat, S.
Lubach, J. W.
Haslam, J. L.
Munson, E. J. [1 ]
Stella, V. I.
机构
[1] Univ Kansas, Dept Pharmaceut Chem, Lawrence, KS 66047 USA
[2] Ctr Drug Delivery Res, Lawrence, KS 66047 USA
基金
美国国家科学基金会;
关键词
solid-state NMR; solid dosage form; physical characterization; osmotic pumps; processing; inclusion compounds; cyclodextrins; granulation;
D O I
10.1002/jps.20798
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
The overall objective of this study was to demonstrate the influence of formulation and processing variables on the physical state of prednisolone (PDL) in formulations consisting of PDL, microcrystalline cellulose (MCC), and sulfobutylether-beta cyclodextrin (CD). PDL was used as a model drug in controlled porosity osmotic pump pellet (CP-OPP) formulations, and was characterized using solid-state NMR spectroscopy and other complimentary analytical techniques. Dosage forms and the solid-state properties of drugs and excipients in a formulation may be influenced by the processing conditions used. Several processing parameters, such as amount of water used in wet granulation and subsequent drying conditions, were found to affect the solid-state transformation of PDL. In addition, the presence of excipients in the CP-OPP was observed to decrease the degree of PDL crystallinity, presumably by creating an inclusion complex with the CD. A hydrated form of PDL was created when PDL was ground with water alone; however, this form was not observed in formulated products. Solid-state NMR spectroscopy was shown to be a powerful technique for the analysis of drug formulations and investigations of the effects of processing conditions. (c) 2007Wiley-Liss, Inc. and the American Pharmacists Association J Pharm Sci 96:1008-1017, 2007.
引用
收藏
页码:1008 / 1017
页数:10
相关论文
共 41 条
[1]   Comparison of the effects of two drying methods on polymorphism of theophylline [J].
Airaksinen, S ;
Karjalainen, M ;
Räsänen, E ;
Rantanen, J ;
Yliruusi, J .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2004, 276 (1-2) :129-141
[2]  
Andrew E.R., 1971, PROGRESS NMR SPECTRO, V8, P1, DOI DOI 10.1016/0079-6565(71)80001-8
[3]   REMOVAL OF DIPOLAR BROADENING OF NUCLEAR MAGNETIC RESONANCE SPECTRA OF SOLIDS BY SPECIMEN ROTATION [J].
ANDREW, ER ;
BRADBURY, A ;
EADES, RG .
NATURE, 1959, 183 (4678) :1802-1803
[4]   EFFECT OF FORMULATION AND PROCESS VARIABLES ON THE DISSOLUTION PROFILE OF NAPROXEN SODIUM FROM TABLETS [J].
BANSAL, P ;
HARIBHAKTI, K ;
SUBRAMANIAN, V ;
PLAKOGIANNIS, F .
DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 1994, 20 (13) :2151-2156
[5]   SOLID-STATE NUCLEAR-MAGNETIC-RESONANCE SPECTROSCOPY - THEORY AND PHARMACEUTICAL APPLICATIONS [J].
BUGAY, DE .
PHARMACEUTICAL RESEARCH, 1993, 10 (03) :317-327
[6]   Effect of processing on celecoxib and its solvates [J].
Chawla, G ;
Bansal, AK .
PHARMACEUTICAL DEVELOPMENT AND TECHNOLOGY, 2004, 9 (04) :419-433
[7]   Modeling and monitoring of polymorphic transformations during the drying phase of wet granulation [J].
Davis, TD ;
Peck, GE ;
Stowell, JG ;
Morris, KR ;
Byrn, SR .
PHARMACEUTICAL RESEARCH, 2004, 21 (05) :860-866
[8]   In situ monitoring of wet granulation using online X-ray powder diffraction [J].
Davis, TD ;
Morris, KR ;
Huang, HP ;
Peck, GE ;
Stowell, JG ;
Eisenhauer, BJ ;
Hilden, JL ;
Gibson, D ;
Byrn, SR .
PHARMACEUTICAL RESEARCH, 2003, 20 (11) :1851-1857
[9]   TOTAL SUPPRESSION OF SIDEBANDS IN CPMAS C-13 NMR [J].
DIXON, WT ;
SCHAEFER, J ;
SEFCIK, MD ;
STEJSKAL, EO ;
MCKAY, RA .
JOURNAL OF MAGNETIC RESONANCE, 1982, 49 (02) :341-345
[10]   Determination of the composition of delavirdine mesylate polymorph and pseudopolymorph mixtures using C-13 CP/MAS NMR [J].
Gao, P .
PHARMACEUTICAL RESEARCH, 1996, 13 (07) :1095-1104